Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2004 Nov;80(949):642–649. doi: 10.1136/pgmj.2004.020891

Cachexia in malaria and heart failure: therapeutic considerations in clinical practice

M Onwuamaegbu 1, M Henein 1, A Coats 1
PMCID: PMC1743137  PMID: 15537847

Abstract

Cachexia is an independent prognostic marker of survival in many chronic diseases including heart failure and malaria. Morbidity and mortality from malaria is high in most of the third world where it presents a very challenging public health problem. Malaria may present in the UK as fever in the returning traveller or as fever in overseas visitors. How and why cachexia develops in malaria in a manner similar to the cachexia of chronic heart failure and the treatment strategies that would alter outcomes in both diseases are discussed in this review.

Full Text

The Full Text of this article is available as a PDF (103.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adigun A. Q., Ajayi A. A. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Eur J Heart Fail. 2001 Jun;3(3):359–363. doi: 10.1016/s1388-9842(00)00146-x. [DOI] [PubMed] [Google Scholar]
  2. Akanmori B. D., Kurtzhals J. A., Goka B. Q., Adabayeri V., Ofori M. F., Nkrumah F. K., Behr C., Hviid L. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur Cytokine Netw. 2000 Mar;11(1):113–118. [PubMed] [Google Scholar]
  3. Allan R. J., Beattie P., Bate C., Van Hensbroek M. B., Morris-Jones S., Greenwood B. M., Kwiatkowski D. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect Immun. 1995 Apr;63(4):1173–1175. doi: 10.1128/iai.63.4.1173-1175.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anker S. D., Chua T. P., Ponikowski P., Harrington D., Swan J. W., Kox W. J., Poole-Wilson P. A., Coats A. J. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997 Jul 15;96(2):526–534. doi: 10.1161/01.cir.96.2.526. [DOI] [PubMed] [Google Scholar]
  5. Anker Stefan D., Negassa Abdissa, Coats Andrew J. S., Afzal Rizwan, Poole-Wilson Philip A., Cohn Jay N., Yusuf Salim. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003 Mar 29;361(9363):1077–1083. doi: 10.1016/S0140-6736(03)12892-9. [DOI] [PubMed] [Google Scholar]
  6. Barnes Peter J. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol. 2002;42:81–98. doi: 10.1146/annurev.pharmtox.42.111901.111143. [DOI] [PubMed] [Google Scholar]
  7. Bhidayasiri R., Truong D. D. Chorea and related disorders. Postgrad Med J. 2004 Sep;80(947):527–534. doi: 10.1136/pgmj.2004.019356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bozkurt B., Villaneuva F. S., Holubkov R., Tokarczyk T., Alvarez R. J., Jr, MacGowan G. A., Murali S., Rosenblum W. D., Feldman A. M., McNamara D. M. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999 Jul;34(1):177–180. doi: 10.1016/s0735-1097(99)00161-8. [DOI] [PubMed] [Google Scholar]
  9. Carr J. G., Stevenson L. W., Walden J. A., Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1989 Mar 15;63(11):709–713. doi: 10.1016/0002-9149(89)90256-7. [DOI] [PubMed] [Google Scholar]
  10. Carswell F., Hughes A. O., Palmer R. I., Higginson J., Harland P. S., Meakins R. H. Nutritional status, globulin titers, and parasitic infections of two populations of Tanzanian school children. Am J Clin Nutr. 1981 Jul;34(7):1292–1299. doi: 10.1093/ajcn/34.7.1292. [DOI] [PubMed] [Google Scholar]
  11. Cicoira M., Bolger A. P., Doehner W., Rauchhaus M., Davos C., Sharma R., Al-Nasser F. O., Coats A. J., Anker S. D. High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine. 2001 Jul 21;15(2):80–86. doi: 10.1006/cyto.2001.0918. [DOI] [PubMed] [Google Scholar]
  12. Clark I. A., Rockett K. A. Nitric oxide and parasitic disease. Adv Parasitol. 1996;37:1–56. doi: 10.1016/s0065-308x(08)60218-3. [DOI] [PubMed] [Google Scholar]
  13. Clark Ian A., Awburn Melissa M., Whitten Richard O., Harper Clive G., Liomba N. George, Molyneux Malcolm E., Taylor Terrie E. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar J. 2003 Apr 8;2:6–6. doi: 10.1186/1475-2875-2-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clark Ian A., Cowden William B. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003 Aug;99(2):221–260. doi: 10.1016/s0163-7258(03)00060-3. [DOI] [PubMed] [Google Scholar]
  15. Coats A. J., Adamopoulos S., Meyer T. E., Conway J., Sleight P. Effects of physical training in chronic heart failure. Lancet. 1990 Jan 13;335(8681):63–66. doi: 10.1016/0140-6736(90)90536-e. [DOI] [PubMed] [Google Scholar]
  16. Coats A. J., Clark A. L., Piepoli M., Volterrani M., Poole-Wilson P. A. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J. 1994 Aug;72(2 Suppl):S36–S39. doi: 10.1136/hrt.72.2_suppl.s36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Coats A. J. The "muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol. 1996 Nov;28(11):2255–2262. doi: 10.1006/jmcc.1996.0218. [DOI] [PubMed] [Google Scholar]
  18. DAVIS J. O. Mechanisms of salt and water retention in congestive heart failure. The importance of aldosterone. Am J Med. 1960 Sep;29:486–507. doi: 10.1016/0002-9343(60)90045-0. [DOI] [PubMed] [Google Scholar]
  19. Davis T. M., Pukrittayakamee S., Supanaranond W., Looareesuwan S., Krishna S., Nagachinta B., Turner R. C., White N. J. Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria. Clin Endocrinol (Oxf) 1990 Dec;33(6):739–749. doi: 10.1111/j.1365-2265.1990.tb03911.x. [DOI] [PubMed] [Google Scholar]
  20. Deen J. L., Walraven G. E. L., von Seidlein L. Increased risk for malaria in chronically malnourished children under 5 years of age in rural Gambia. J Trop Pediatr. 2002 Apr;48(2):78–83. doi: 10.1093/tropej/48.2.78. [DOI] [PubMed] [Google Scholar]
  21. Di Perri G., Di Perri I. G., Monteiro G. B., Bonora S., Hennig C., Cassatella M., Micciolo R., Vento S., Dusi S., Bassetti D. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis. 1995 May;171(5):1317–1322. doi: 10.1093/infdis/171.5.1317. [DOI] [PubMed] [Google Scholar]
  22. Doehner W., Pflaum C. D., Rauchhaus M., Godsland I. F., Egerer K., Cicoira M., Florea V. G., Sharma R., Bolger A. P., Coats A. J. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol. 2001 Dec;145(6):727–735. doi: 10.1530/eje.0.1450727. [DOI] [PubMed] [Google Scholar]
  23. Domínguez-Vázquez A., Alzate-Sánchez A. Estado nutricional en niños menores de seis años y su asociación con malaria y parasitismo intestinal. Salud Publica Mex. 1990 Jan-Feb;32(1):52–63. [PubMed] [Google Scholar]
  24. Drexler H., Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol. 1999 Jan;31(1):51–60. doi: 10.1006/jmcc.1998.0843. [DOI] [PubMed] [Google Scholar]
  25. Feingold K. R., Serio M. K., Adi S., Moser A. H., Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology. 1989 May;124(5):2336–2342. doi: 10.1210/endo-124-5-2336. [DOI] [PubMed] [Google Scholar]
  26. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res. 1999 Aug;40(2):97–105. doi: 10.1006/phrs.1998.0463. [DOI] [PubMed] [Google Scholar]
  27. Genton B., Al-Yaman F., Ginny M., Taraika J., Alpers M. P. Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children. Am J Clin Nutr. 1998 Sep;68(3):734–741. doi: 10.1093/ajcn/68.3.734. [DOI] [PubMed] [Google Scholar]
  28. Gullestad L., Aass H., Fjeld J. G., Wikeby L., Andreassen A. K., Ihlen H., Simonsen S., Kjekshus J., Nitter-Hauge S., Ueland T. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation. 2001 Jan 16;103(2):220–225. doi: 10.1161/01.cir.103.2.220. [DOI] [PubMed] [Google Scholar]
  29. Hendrickse R. G., Hasan A. H., Olumide L. O., Akinkunmi A. Malaria in early childhood. An investigation of five hundred seriously ill children in whom a "clinical" diagnosis of malaria was made on admission to the children's emergency room at University College Hospital, Ibadan. Ann Trop Med Parasitol. 1971 Mar;65(1):1–20. [PubMed] [Google Scholar]
  30. Hensmann M., Kwiatkowski D. Cellular basis of early cytokine response to Plasmodium falciparum. Infect Immun. 2001 Apr;69(4):2364–2371. doi: 10.1128/IAI.69.4.2364-2371.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hirunpetcharat C., Finkelman F., Clark I. A., Good M. F. Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol. 1999 Jun;21(6):319–329. doi: 10.1046/j.1365-3024.1999.00234.x. [DOI] [PubMed] [Google Scholar]
  32. Hoffman Stephen L., Subramanian G. Mani, Collins Frank H., Venter J. Craig. Plasmodium, human and Anopheles genomics and malaria. Nature. 2002 Feb 7;415(6872):702–709. doi: 10.1038/415702a. [DOI] [PubMed] [Google Scholar]
  33. Hotez P. J., Le Trang N., Fairlamb A. H., Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by a haematoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunol. 1984 May;6(3):203–209. doi: 10.1111/j.1365-3024.1984.tb00793.x. [DOI] [PubMed] [Google Scholar]
  34. James T. N. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 1994 Jul;90(1):556–573. [PubMed] [Google Scholar]
  35. Jason J., Archibald L. K., Nwanyanwu O. C., Byrd M. G., Kazembe P. N., Dobbie H., Jarvis W. R. Comparison of serum and cell-specific cytokines in humans. Clin Diagn Lab Immunol. 2001 Nov;8(6):1097–1103. doi: 10.1128/CDLI.8.6.1097-1103.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. KATZ A. M., KATZ P. B. Diseases of the heart in the works of Hippocrates. Br Heart J. 1962 May;24:257–264. doi: 10.1136/hrt.24.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kain K. C., Keystone J. S. Malaria in travelers. Epidemiology, disease, and prevention. Infect Dis Clin North Am. 1998 Jun;12(2):267–284. doi: 10.1016/s0891-5520(05)70005-2. [DOI] [PubMed] [Google Scholar]
  38. Karunaweera N. D., Grau G. E., Gamage P., Carter R., Mendis K. N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200–3203. doi: 10.1073/pnas.89.8.3200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kern P., Hemmer C. J., Van Damme J., Gruss H. J., Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989 Aug;87(2):139–143. doi: 10.1016/s0002-9343(89)80688-6. [DOI] [PubMed] [Google Scholar]
  40. Kjekshus John. Debate: Statins should be used in patients with heart failure. Curr Control Trials Cardiovasc Med. 2001;2(6):268–270. doi: 10.1186/cvm-2-6-268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Krown K. A., Page M. T., Nguyen C., Zechner D., Gutierrez V., Comstock K. L., Glembotski C. C., Quintana P. J., Sabbadini R. A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996 Dec 15;98(12):2854–2865. doi: 10.1172/JCI119114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kubo S. H. The role of neurohormonal activation in the pathophysiology and prognosis of patients with congestive heart failure. Coron Artery Dis. 1993 Jan;4(1):4–15. doi: 10.1097/00019501-199301000-00002. [DOI] [PubMed] [Google Scholar]
  43. Kurtzhals J. A., Adabayeri V., Goka B. Q., Akanmori B. D., Oliver-Commey J. O., Nkrumah F. K., Behr C., Hviid L. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998 Jun 13;351(9118):1768–1772. doi: 10.1016/S0140-6736(97)09439-7. [DOI] [PubMed] [Google Scholar]
  44. Kwiatkowski D., Hill A. V., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R., Greenwood B. M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 Nov 17;336(8725):1201–1204. doi: 10.1016/0140-6736(90)92827-5. [DOI] [PubMed] [Google Scholar]
  45. LARAGH J. H. Hormones and the pathogenesis of congestive heart failure: vasopressin, aldosterone, and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and in cirrhosis. Circulation. 1962 Jun;25:1015–1023. doi: 10.1161/01.cir.25.6.1015. [DOI] [PubMed] [Google Scholar]
  46. Levine B., Kalman J., Mayer L., Fillit H. M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241. doi: 10.1056/NEJM199007263230405. [DOI] [PubMed] [Google Scholar]
  47. Lipkin D. P., Jones D. A., Round J. M., Poole-Wilson P. A. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol. 1988 Feb;18(2):187–195. doi: 10.1016/0167-5273(88)90164-7. [DOI] [PubMed] [Google Scholar]
  48. Mbago M. C., Namfua P. P. Some determinants of nutritional status of one- to four-year-old children in low income urban areas in Tanzania. J Trop Pediatr. 1992 Dec;38(6):299–306. doi: 10.1093/tropej/38.6.299. [DOI] [PubMed] [Google Scholar]
  49. McNamara D. M., Holubkov R., Starling R. C., Dec G. W., Loh E., Torre-Amione G., Gass A., Janosko K., Tokarczyk T., Kessler P. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001 May 8;103(18):2254–2259. doi: 10.1161/01.cir.103.18.2254. [DOI] [PubMed] [Google Scholar]
  50. Migot-Nabias F., Deloron P., Ringwald P., Dubois B., Mayombo J., Minh T. N., Fievet N., Millet P., Luty A. Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):557–562. doi: 10.1016/s0035-9203(00)90086-5. [DOI] [PubMed] [Google Scholar]
  51. Minotti J. R., Pillay P., Oka R., Wells L., Christoph I., Massie B. M. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol (1985) 1993 Jul;75(1):373–381. doi: 10.1152/jappl.1993.75.1.373. [DOI] [PubMed] [Google Scholar]
  52. Modiano D., Petrarca V., Sirima B. S., Nebié I., Diallo D., Esposito F., Coluzzi M. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13206–13211. doi: 10.1073/pnas.93.23.13206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Mohanty S., Mishra S. K., Das B. S., Satpathy S. K., Mohanty D., Patnaik J. K., Bose T. K. Altered plasma lipid pattern in falciparum malaria. Ann Trop Med Parasitol. 1992 Dec;86(6):601–606. doi: 10.1080/00034983.1992.11812715. [DOI] [PubMed] [Google Scholar]
  54. Morrison W. L., Gibson J. N., Rennie M. J. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur J Clin Invest. 1988 Dec;18(6):648–654. doi: 10.1111/j.1365-2362.1988.tb01282.x. [DOI] [PubMed] [Google Scholar]
  55. Nacher M., Singhasivanon P., Vannaphan S., Treeprasertsuk S., Phanumaphorn M., Traore B., Looareesuwan S., Gay F. Socio-economic and environmental protective/risk factors for severe malaria in Thailand. Acta Trop. 2001 Feb 23;78(2):139–146. doi: 10.1016/s0001-706x(00)00184-4. [DOI] [PubMed] [Google Scholar]
  56. Nuhr Martin J., Pette Dirk, Berger Rudolf, Quittan Michael, Crevenna Richard, Huelsman Martin, Wiesinger Guenther F., Moser Petra, Fialka-Moser Veronika, Pacher Richard. Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure. Eur Heart J. 2004 Jan;25(2):136–143. doi: 10.1016/j.ehj.2003.09.027. [DOI] [PubMed] [Google Scholar]
  57. Nussenblatt V., Mukasa G., Metzger A., Ndeezi G., Garrett E., Semba R. D. Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin Diagn Lab Immunol. 2001 Nov;8(6):1164–1170. doi: 10.1128/CDLI.8.6.1164-1170.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Otaki M. Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality. Chest. 1994 May;105(5):1347–1351. doi: 10.1378/chest.105.5.1347. [DOI] [PubMed] [Google Scholar]
  59. Othoro C., Lal A. A., Nahlen B., Koech D., Orago A. S., Udhayakumar V. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis. 1999 Jan;179(1):279–282. doi: 10.1086/314548. [DOI] [PubMed] [Google Scholar]
  60. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992 Jul;20(1):248–254. doi: 10.1016/0735-1097(92)90167-l. [DOI] [PubMed] [Google Scholar]
  61. Pekala P. H., Price S. R., Horn C. A., Hom B. E., Moss J., Cerami A. Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes. Trans Assoc Am Physicians. 1984;97:251–259. [PubMed] [Google Scholar]
  62. Rauchhaus M., Koloczek V., Volk H., Kemp M., Niebauer J., Francis D. P., Coats A. J., Anker S. D. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000 Nov-Dec;76(2-3):125–133. doi: 10.1016/s0167-5273(00)00224-2. [DOI] [PubMed] [Google Scholar]
  63. Remme W. J., Swedberg K., Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001 Sep;22(17):1527–1560. doi: 10.1053/euhj.2001.2783. [DOI] [PubMed] [Google Scholar]
  64. Roubenoff R., Kehayias J. J. The meaning and measurement of lean body mass. Nutr Rev. 1991 Jun;49(6):163–175. doi: 10.1111/j.1753-4887.1991.tb03013.x. [DOI] [PubMed] [Google Scholar]
  65. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991 Sep;45(3):297–308. doi: 10.4269/ajtmh.1991.45.297. [DOI] [PubMed] [Google Scholar]
  66. Schofield L., Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med. 1993 Jan 1;177(1):145–153. doi: 10.1084/jem.177.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sein K. K., Aikawa M. The prime role of plasma membrane cholesterol in the pathogenesis of immune evasion and clinical manifestations of falciparum malaria. Med Hypotheses. 1998 Aug;51(2):105–110. doi: 10.1016/s0306-9877(98)90102-5. [DOI] [PubMed] [Google Scholar]
  68. Singh S., Singh N., Handa R. Tumor necrosis factor-alpha in patients with malaria. Indian J Malariol. 2000 Mar-Jun;37(1-2):27–33. [PubMed] [Google Scholar]
  69. Skudicky D., Bergemann A., Sliwa K., Candy G., Sareli P. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation. 2001 Feb 27;103(8):1083–1088. doi: 10.1161/01.cir.103.8.1083. [DOI] [PubMed] [Google Scholar]
  70. Staalsoe Trine, Shulman Caroline E., Bulmer Judith N., Kawuondo Ken, Marsh Kevin, Hviid Lars. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet. 2004 Jan 24;363(9405):283–289. doi: 10.1016/S0140-6736(03)15386-X. [DOI] [PubMed] [Google Scholar]
  71. Swan J. W., Walton C., Godsland I. F., Clark A. L., Coats A. J., Oliver M. F. Insulin resistance in chronic heart failure. Eur Heart J. 1994 Nov;15(11):1528–1532. doi: 10.1093/oxfordjournals.eurheartj.a060425. [DOI] [PubMed] [Google Scholar]
  72. Tachado S. D., Gerold P., Schwarz R., Novakovic S., McConville M., Schofield L. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4022–4027. doi: 10.1073/pnas.94.8.4022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Tanner M., Burnier E., Mayombana C., Betschart B., de Savigny D., Marti H. P., Suter R., Aellen M., Lüdin E., Degrémont A. A. Longitudinal study on the health status of children in a rural Tanzanian community: parasitoses and nutrition following control measures against intestinal parasites. Acta Trop. 1987 Jun;44(2):137–174. [PubMed] [Google Scholar]
  74. Urban B. C., Ferguson D. J., Pain A., Willcox N., Plebanski M., Austyn J. M., Roberts D. J. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature. 1999 Jul 1;400(6739):73–77. doi: 10.1038/21900. [DOI] [PubMed] [Google Scholar]
  75. Usawattanakul W., Tharavanij S., Warrell D. A., Looareesuwan S., White N. J., Supavej S., Soikratoke S. Factors contributing to the development of cerebral malaria. II. Endotoxin. Clin Exp Immunol. 1985 Sep;61(3):562–568. [PMC free article] [PubMed] [Google Scholar]
  76. Van Den Broeck J., Eeckels R., Vuylsteke J. Influence of nutritional status on child mortality in rural Zaire. Lancet. 1993 Jun 12;341(8859):1491–1495. doi: 10.1016/0140-6736(93)90632-q. [DOI] [PubMed] [Google Scholar]
  77. Wattavidanage J., Carter R., Perera K. L., Munasingha A., Bandara S., McGuinness D., Wickramasinghe A. R., Alles H. K., Mendis K. N., Premawansa S. TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin Exp Immunol. 1999 Feb;115(2):350–355. doi: 10.1046/j.1365-2249.1999.00804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES